176 related articles for article (PubMed ID: 3116371)
1. Human macrophage-activating factors for cytotoxicity. I. Establishment of a human T-cell hybridoma that produces macrophage-activating factors for cytotoxicity.
Higuchi M; Sugimoto M; Kobayashi Y; Osawa T
Microbiol Immunol; 1987; 31(5):469-79. PubMed ID: 3116371
[TBL] [Abstract][Full Text] [Related]
2. Human macrophage-activating factors for cytotoxicity. II. Synergism of two factors produced by a human T-cell hybridoma that induce the cytotoxicity of human monocytes.
Higuchi M; Sugimoto M; Kobayashi Y; Osawa T
Microbiol Immunol; 1987; 31(5):481-90. PubMed ID: 3116372
[TBL] [Abstract][Full Text] [Related]
3. Macrophage-activating factor for cytotoxicity produced by a human T-cell hybridoma.
Higuchi M; Nakamura N; Tsuchiya SI; Kobayashi Y; Osawa T
Cell Immunol; 1984 Sep; 87(2):626-36. PubMed ID: 6205774
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.
Celada A; Gray PW; Rinderknecht E; Schreiber RD
J Exp Med; 1984 Jul; 160(1):55-74. PubMed ID: 6330272
[TBL] [Abstract][Full Text] [Related]
5. Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF).
De Groot JW; De Weger RA; Vandebriel RJ; Den Otter W
Immunobiology; 1989 Jun; 179(2-3):131-44. PubMed ID: 2676851
[TBL] [Abstract][Full Text] [Related]
6. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J
J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232
[TBL] [Abstract][Full Text] [Related]
7. Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line.
Kleinerman ES; Zicht R; Sarin PS; Gallo RC; Fidler IJ
Cancer Res; 1984 Oct; 44(10):4470-5. PubMed ID: 6088039
[TBL] [Abstract][Full Text] [Related]
8. Identification of human T cell hybridoma-derived macrophage activating factor as interleukin-2.
Higashi N; Higuchi M; Hanada N; Oeda J; Kobayashi Y; Osawa T
J Biochem; 1993 Jun; 113(6):715-20. PubMed ID: 8370669
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a human T-cell hybridoma that produces human macrophage activating factor for superoxide production and translation of messenger RNA of the factor in Xenopus laevis oocyte.
Miyamoto D; Nakamura N; Ishii Y; Kobayashi Y; Osawa T
Mol Immunol; 1987 Mar; 24(3):239-45. PubMed ID: 3039355
[TBL] [Abstract][Full Text] [Related]
10. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
Kern DE; Grabstein KH; Okuno K; Schreiber RD; Greenberg PD
J Immunol; 1989 Dec; 143(12):4308-16. PubMed ID: 2687379
[TBL] [Abstract][Full Text] [Related]
11. Constitutive production of novel macrophage-activating factor(s) by human T cell hybridomas.
Taniyama T; Taki S; Akiyama Y; Yoshizawa K; Hamuro J; Arai K; Wong GG
Clin Invest Med; 1990 Dec; 13(6):305-12. PubMed ID: 2127737
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma.
Lee JC; Rebar L; Young P; Ruscetti FW; Hanna N; Poste G
J Immunol; 1986 Feb; 136(4):1322-8. PubMed ID: 3003193
[TBL] [Abstract][Full Text] [Related]
13. The production of a cytotoxic factor by mouse peritoneal macrophages and macrophage hybridomas treated with various stimulating agents.
Takeda Y; Higuchi M; Sugimoto M; Shimoda O; Woo HJ; Shimada S; Osawa T
Microbiol Immunol; 1986; 30(2):143-54. PubMed ID: 3086676
[TBL] [Abstract][Full Text] [Related]
14. Identification of a T cell hybridoma that produces large quantities of macrophage-activating factor.
Schreiber RD; Altman A; Katz DH
J Exp Med; 1982 Sep; 156(3):677-89. PubMed ID: 7050288
[TBL] [Abstract][Full Text] [Related]
15. Similarities of murine gamma interferon and the lymphokine that renders macrophages cytotoxic.
Kleinschmidt WJ; Schultz RM
J Interferon Res; 1982; 2(2):291-9. PubMed ID: 6811671
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon.
Schreiber RD; Pace JL; Russell SW; Altman A; Katz DH
J Immunol; 1983 Aug; 131(2):826-32. PubMed ID: 6408190
[TBL] [Abstract][Full Text] [Related]
18. Human lymphokine preparations which generate tumoricidal properties of human monocytes in vitro may be distinct from gamma interferon.
Kleinerman ES; Wiltrout RH; Zicht R; Fidler IJ
Cancer Immunol Immunother; 1985; 20(2):151-7. PubMed ID: 3930068
[TBL] [Abstract][Full Text] [Related]
19. Human T-cell hybridomas producing migration inhibitory factor and macrophage activating factors.
Higuchi M; Asada M; Kobayashi Y; Osawa T
Cell Immunol; 1983 Jun; 78(2):257-65. PubMed ID: 6305517
[TBL] [Abstract][Full Text] [Related]
20. T-cell hybridoma production of macrophage activation factor (MAF) I. Separation of MAF from interferon gamma.
Ratliff TL; Thomasson DL; McCool RE; Catalona WJ
J Reticuloendothel Soc; 1982 May; 31(5):393-7. PubMed ID: 6181257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]